Inflammation and immunity in the tumor environment

Digestive Diseases

Volumn 28, Issue 4-5, 2010, Pages 574-578

  Maletzki, C ^a   Emmrich, J ^a  

^a ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

Author keywords

Chronic inflammation; Persistent inflammation; Tumor environment

Indexed keywords

ANIMAL MODEL; BACTERIAL STRAIN; CANCER IMMUNOTHERAPY; CANCER MODEL; CANCER PREVENTION; CANCER THERAPY; CONFERENCE PAPER; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOTHERAPY; INFLAMMATION; NONHUMAN; PANCREAS CARCINOMA; PRIORITY JOURNAL; STREPTOCOCCUS PYOGENES; TUMOR CELL; TUMOR MICROENVIRONMENT; TUMOR REGRESSION;

ANIMALS; CHRONIC DISEASE; HUMANS; IMMUNITY; INFLAMMATION; MACROPHAGES; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; NEOPLASMS; PANCREATIC NEOPLASMS; T-LYMPHOCYTES; TUMOR MICROENVIRONMENT;

EID: 78649347028     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000321062     Document Type: Conference Paper

References (12)

1. Grivennikov SI, Greten FR, Karin M: Immunity, inflammation, and cancer, Cell 2010; 140:883-899.
2. Mantovani A, Allavena P, Sica A, Balkwill F: Cancer-related inflammation. Nature 2008; 454: 436-444.
3. Sica A, Allavena P, Mantovani A: Cancer related inflammation: the macrophage connection. Cancer Lett 2008; 267: 204-215.
4. DeNardo DG, Barreto JB, Andreu P, Vasquez L, Tawfik D, Kolhatkar N, Coussens LM: CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell 2009; 16:91-102.
5. Polyak K, Weinberg RA: Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Ca ncer 20 09; 9: 265-273.
6. Wiemann B, Starnes CO: Coley's toxins, tumor necrosis factor and cancer research: a historical perspective. Pharmacol Ther 1994; 64:529-564.
7. Staib L, Link KH, Beger HG: Immunotherapy in pancreatic cancer - current status and future. Langenbecks Arch Surg 1999; 384: 396-404.
8. Hobohm U, Stanford JL, Grange JM: Pathogen-associated molecular pattern in cancer immunotherapy. Crit Rev Immunol 2008; 28: 95-107.
9. Melief CJ, Toes RE, Medema JP, et al: Strategies for immunotherapy of cancer. Adv Immunol 2000; 75: 235-282.
10. Dang LH, Bettegowda C, Huso DL, et al: Combination bacteriolytic therapy for the treatment of experimental tumors. Proc Natl Acad Sci USA 2001; 98:15155-15160.
11. Fraser JD, Proft T: The bacterial superantigen and superantigen-like proteins. Immunol Rev 2008; 225:226-243.
12. Nelson D, Schuch R, Chahales P, et al: PlyC: a multimeric bacteriophage lysin. Proc Natl Acad Sci USA 2006; 103:10765-10770.